Sign Up to like & get
recommendations!
2
Published in 2023 at "Expert opinion on drug safety"
DOI: 10.1080/14740338.2023.2193391
Abstract: OBJECTIVES Taxane-related neurotoxicity is a frequent clinical problem but lacks postmarketing data regarding neurological disorders. This study aimed to evaluate the potential association between neurological adverse events and several taxane-derived drugs via the Food and…
read more here.
Keywords:
taxane;
neurological adverse;
analysis;
derived drugs ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Melanoma Research"
DOI: 10.1097/cmr.0000000000000825
Abstract: Anti-programmed cell death protein 1 (PD1) antibodies, pembrolizumab and nivolumab, alone or in combination with ipilimumab, have become standard treatment for melanoma and multiple other malignancies. Neurological adverse effects are rare and have not been…
read more here.
Keywords:
adverse effects;
neurological adverse;
pd1 antibodies;
alone combination ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000030236
Abstract: INTRODUCTION The indications for immune checkpoint inhibitors (ICIs) are expanding for various cancers because of their durable responses and tolerable safety profiles. Immune-related adverse events (irAEs), including neurological adverse events (nAEs), are associated with ICIs…
read more here.
Keywords:
checkpoint inhibitors;
immune checkpoint;
immune related;
neurological adverse ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal for ImmunoTherapy of Cancer"
DOI: 10.1136/jitc-2020-sitc2020.0651
Abstract: Background Immune checkpoint inhibitors (ICIs) have become a revolution in the treatment of many tumoral diseases, resulting in a significant increase in terms of life expectancy and quality of life.Despite these outstanding advances in long-life…
read more here.
Keywords:
immune checkpoint;
checkpoint inhibitors;
neurological adverse;
treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Immunotherapy"
DOI: 10.2217/imt-2020-0161
Abstract: Aim: To characterize real-world neurological adverse events (AEs) associated with chimeric antigen receptor T-cell therapies in patients with refractory/relapsed large B-cell lymphomas. Materials & methods: Postmarketing case reports from the US FDA AEs reporting system involving axicabtagene ciloleucel (axi-cel)…
read more here.
Keywords:
real world;
neurological adverse;
adverse events;
cell ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Clinical Psychopharmacology and Neuroscience"
DOI: 10.9758/cpn.2023.21.2.222
Abstract: SARS-CoV-2 vaccines are not free of side effects and most commonly affect the central or peripheral nervous system (CNS, PNS). This narrative review aims to summarise recent advances in the nature, frequency, management, and outcome…
read more here.
Keywords:
neurological side;
cov vaccines;
side effects;
neurological adverse ... See more keywords